Aurobindo Pharma Limited announced the appointment of N. Ravikiran as Chief Business Officer of the company, with effect from March 5, 2024. According to the company’s exchange filing, “Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform that upon recommendation of the Nomination and Remuneration Committee, the…